Clinical Trials Browser

Adenocarcinoma, Carcinoma, Melanoma, Neuroendocrine Tumors

NCT07124000 2026-06-01

DP-04

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

NCT06807398 2026-05-15

RF-2018-123683

Completed

367 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06862856 2026-05-15

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Recruiting

50 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07237399 2026-05-13

TA-P-OLIM

Withdrawn

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06661044 2026-04-30

EVENTIDE

Completed

6 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07439913 2026-04-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Enrolling by invitation

120 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07484971 2026-04-17

CLIQQC

Recruiting

2,000 enrolled

Genitourinary

Adenocarcinoma, Disease, Neoplasms, Prostatic Neoplasms

NCT07516886 2026-04-08

PPSARP

Recruiting

500 enrolled

Genitourinary

Adenocarcinoma, Disease, Prostatic Neoplasms

NCT06504615 2026-04-03

METAGIO

Active not recruiting

208 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma

NCT06128343 2026-03-19

BACAP-2

Recruiting

1,500 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasms

NCT06902545 2026-03-11

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Recruiting

377 enrolled

Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT07460726 2026-03-10

PRIAPUS-PCa

Not yet recruiting

130 enrolled

Genitourinary

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

NCT06996249 2026-03-03

DuTOC

Recruiting

12,000 enrolled

Other solid neoplasmThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

NCT07407608 2026-02-12

ABRUPT 2

Recruiting

58 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT00349830 2026-02-10

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Recruiting

2,000 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasms

NCT06834152 2026-02-09

X-SMILE

Recruiting

75 enrolled

Genitourinary

Adenocarcinoma, Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT07370597 2026-01-27

LUDOPATH

Recruiting

110 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT05812027 2025-11-17

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Active not recruiting

1,150 enrolled

DermatologicGynecologicHead & NeckSarcomaThoracic

Uveal Melanoma, Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Sarcoma

NCT06358001 2025-09-22

EchoTip AcuCore Post-Market Clinical Study

Completed

183 enrolled

EndocrineGastrointestinalLymphoidNET

Autoimmune Pancreatitis, Adenocarcinoma, Carcinoma, Hepatocellular, Lymphoma, Neoplasm Metastasis, Cholangiocarcinoma, Neuroendocrine Tumors, Pancreatitis, Chronic

NCT06605404 2025-08-14